A combination of Follicle Stimulating Hormone (F.S.H.) and Luteinizing Hormone (L.H.) derived from menopausal women. These hormones are used to induce ovulation of one or more eggs.
« Back to Glossary Index
« Back to Glossary Index
- 2026 Benefits Planning: Fertility Benefits for Employees Should Be a Top Workforce Priority
As employers plan for 2026, fertility benefits for employees are becoming essential. Learn why demand is rising and how ARC Fertility helps create a fertility-friendly workplace. - Supporting Mental Health in the Workplace During Fertility Treatment
Fertility treatment can take a toll on employees’ mental health. Learn why mental health support during fertility treatment matters at work. - Heart Health & Fertility: Why Supporting Maternal Well-Being Protects Workforce Health
Maternal health benefits for employees protect heart health, fertility, and workforce well-being. Learn why employers should act during Heart Month. - Closing Gaps in Black Maternal Health: How Employers Can Improve Care Access and Outcomes
Black maternal health disparities remain a workforce issue. Learn how Black maternal health support for employees improves care access and outcomes. - Paternal Perinatal Depression: Why Employers Should Pay Attention
Paternal perinatal depression affects many new fathers. Learn why employers should understand the signs and support mental health during early parenthood.